{"transactions":[{"id":1966155,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:24:38.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date."}],"balance_after":17500,"derivative":{"expiration_date":"2025-03-05","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001209191-23-016739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919123016739/doc4.xml","form_type":"4"}},{"id":1966154,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:24:38.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":23625,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001209191-23-016739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919123016739/doc4.xml","form_type":"4"}},{"id":1966153,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:24:38.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/2 of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date."}],"balance_after":40000,"derivative":{"expiration_date":"2025-03-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-016739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919123016739/doc4.xml","form_type":"4"}},{"id":1966152,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2023-03-07T16:24:38.000Z","date":"2023-03-03","kind":"tax_withholding","acquired":false,"shares":6222,"price":5.79,"value":36025.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":40827,"source":{"system":"sec-edgar","filing":"0001209191-23-016739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919123016739/doc4.xml","form_type":"4"}},{"id":1966151,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2023-03-07T16:24:38.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":8750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."}],"balance_after":47049,"source":{"system":"sec-edgar","filing":"0001209191-23-016739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919123016739/doc4.xml","form_type":"4"}},{"id":1966150,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2023-03-07T16:24:38.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":7875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."}],"balance_after":38299,"source":{"system":"sec-edgar","filing":"0001209191-23-016739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919123016739/doc4.xml","form_type":"4"}},{"id":2040403,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-01-31T17:21:37.000Z","date":"2023-01-27","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":4500,"derivative":{"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001209191-23-005754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919123005754/doc4.xml","form_type":"4"}},{"id":2040402,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2023-01-31T17:21:37.000Z","date":"2023-01-27","kind":"tax_withholding","acquired":false,"shares":1835,"price":7.5,"value":13762.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":30424,"source":{"system":"sec-edgar","filing":"0001209191-23-005754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919123005754/doc4.xml","form_type":"4"}},{"id":2040401,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2023-01-31T17:21:37.000Z","date":"2023-01-27","kind":"exercise","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32259,"source":{"system":"sec-edgar","filing":"0001209191-23-005754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919123005754/doc4.xml","form_type":"4"}},{"id":2348081,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-03-07T19:18:55.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date."}],"balance_after":26250,"derivative":{"expiration_date":"2025-03-05","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001209191-22-016850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919122016850/doc4.xml","form_type":"4"}},{"id":2348080,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-03-07T19:18:55.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":31500,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-22-016850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919122016850/doc4.xml","form_type":"4"}},{"id":2348079,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2022-03-07T19:18:55.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 2.0833% of the total shares monthly, beginning on April 4, 2022, with 100% of the total shares vested and exercisable on March 4, 2026, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":42000,"derivative":{"exercise_price":8.17,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001209191-22-016850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919122016850/doc4.xml","form_type":"4"}},{"id":2348078,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2022-03-07T19:18:55.000Z","date":"2022-03-05","kind":"tax_withholding","acquired":false,"shares":3200,"price":8.17,"value":26144.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":27759,"source":{"system":"sec-edgar","filing":"0001209191-22-016850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919122016850/doc4.xml","form_type":"4"}},{"id":2348077,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2022-03-07T19:18:55.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":8750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."}],"balance_after":30959,"source":{"system":"sec-edgar","filing":"0001209191-22-016850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919122016850/doc4.xml","form_type":"4"}},{"id":2419394,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-02-01T20:32:43.000Z","date":"2021-01-29","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":9000,"derivative":{"expiration_date":"2025-01-29","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001209191-22-006121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919122006121/doc4.xml","form_type":"4"}},{"id":2419393,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2022-02-01T20:32:43.000Z","date":"2022-01-29","kind":"tax_withholding","acquired":false,"shares":1844,"price":10.39,"value":19159.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":22209,"source":{"system":"sec-edgar","filing":"0001209191-22-006121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919122006121/doc4.xml","form_type":"4"}},{"id":2419392,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2022-02-01T20:32:43.000Z","date":"2022-01-29","kind":"exercise","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24053,"source":{"system":"sec-edgar","filing":"0001209191-22-006121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919122006121/doc4.xml","form_type":"4"}},{"id":2557744,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2021-09-28T18:53:47.000Z","date":"2021-09-24","kind":"exercise","acquired":false,"shares":8609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2021-09-26","underlying":"Common Stock","underlying_shares":8609},"source":{"system":"sec-edgar","filing":"0001209191-21-057976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919121057976/doc4.xml","form_type":"4"}},{"id":2557743,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2021-09-28T18:53:47.000Z","date":"2021-09-24","kind":"tax_withholding","acquired":false,"shares":2976,"price":19.23,"value":57228.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":19553,"source":{"system":"sec-edgar","filing":"0001209191-21-057976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919121057976/doc4.xml","form_type":"4"}},{"id":2557742,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2021-09-28T18:53:47.000Z","date":"2021-09-24","kind":"exercise","acquired":true,"shares":8609,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22529,"source":{"system":"sec-edgar","filing":"0001209191-21-057976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919121057976/doc4.xml","form_type":"4"}},{"id":2803399,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2021-03-08T17:17:10.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date."}],"balance_after":35000,"derivative":{"expiration_date":"2025-03-05","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-21-018618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919121018618/doc4.xml","form_type":"4"}},{"id":2803398,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2021-03-08T17:17:10.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares monthly, beginning on April 5, 2021, with 100% of the total shares vested and exercisable on March 5, 2025, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":21.11,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-018618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919121018618/doc4.xml","form_type":"4"}},{"id":2888812,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2021-02-01T17:53:16.000Z","date":"2021-01-29","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":13500,"derivative":{"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001209191-21-006554","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919121006554/doc4.xml","form_type":"4"}},{"id":2888811,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2021-02-01T17:53:16.000Z","date":"2021-01-29","kind":"tax_withholding","acquired":false,"shares":1845,"price":22.15,"value":40866.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":13920,"source":{"system":"sec-edgar","filing":"0001209191-21-006554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919121006554/doc4.xml","form_type":"4"}},{"id":2888810,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2021-02-01T17:53:16.000Z","date":"2021-01-29","kind":"exercise","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15765,"source":{"system":"sec-edgar","filing":"0001209191-21-006554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919121006554/doc4.xml","form_type":"4"}},{"id":3021741,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2020-09-28T17:53:06.000Z","date":"2020-09-25","kind":"exercise","acquired":false,"shares":8609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date."}],"balance_after":8609,"derivative":{"expiration_date":"2021-09-26","underlying":"Common Stock","underlying_shares":8609},"source":{"system":"sec-edgar","filing":"0001209191-20-052244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919120052244/doc4.xml","form_type":"4"}},{"id":3021740,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2020-09-28T17:53:06.000Z","date":"2020-09-25","kind":"tax_withholding","acquired":false,"shares":2976,"price":10.3,"value":30652.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":11265,"source":{"system":"sec-edgar","filing":"0001209191-20-052244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919120052244/doc4.xml","form_type":"4"}},{"id":3021739,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2020-09-28T17:53:06.000Z","date":"2020-09-25","kind":"exercise","acquired":true,"shares":8609,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14241,"source":{"system":"sec-edgar","filing":"0001209191-20-052244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919120052244/doc4.xml","form_type":"4"}},{"id":3296797,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2020-01-31T17:15:11.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":18000,"derivative":{"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-20-005806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919120005806/doc4.xml","form_type":"4"}},{"id":3296796,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2020-01-31T17:15:11.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":41250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares monthly, beginning on February 29, 2020, with 100% of the total shares vested and exercisable on January 29, 2024, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":41250,"derivative":{"exercise_price":10.09,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":41250},"source":{"system":"sec-edgar","filing":"0001209191-20-005806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919120005806/doc4.xml","form_type":"4"}},{"id":3404551,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2019-09-30T17:19:22.000Z","date":"2019-09-26","kind":"exercise","acquired":false,"shares":8608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date."}],"balance_after":17218,"derivative":{"expiration_date":"2021-09-26","underlying":"Common Stock","underlying_shares":8608},"source":{"system":"sec-edgar","filing":"0001209191-19-051117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919119051117/doc4.xml","form_type":"4"}},{"id":3404550,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2019-09-30T17:19:22.000Z","date":"2019-09-26","kind":"tax_withholding","acquired":false,"shares":2976,"price":9.74,"value":28986.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":5632,"source":{"system":"sec-edgar","filing":"0001209191-19-051117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919119051117/doc4.xml","form_type":"4"}},{"id":3404549,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Common Stock","published_at":"2019-09-30T17:19:22.000Z","date":"2019-09-26","kind":"exercise","acquired":true,"shares":8608,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8608,"source":{"system":"sec-edgar","filing":"0001209191-19-051117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919119051117/doc4.xml","form_type":"4"}},{"id":3681338,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2019-01-31T17:07:49.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares monthly, beginning on February 28, 2019, with 100% of the total shares vested and exercisable on January 29, 2023, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":10.45,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-19-006201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919119006201/doc4.xml","form_type":"4"}},{"id":3806641,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2018-09-27T17:49:07.000Z","date":"2018-09-26","kind":"grant","acquired":true,"shares":25826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date."}],"balance_after":25826,"derivative":{"expiration_date":"2021-09-25","underlying":"Common Stock","underlying_shares":25826},"source":{"system":"sec-edgar","filing":"0001209191-18-052477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919118052477/doc4.xml","form_type":"4"}},{"id":3806640,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":115853,"kind":"person","name":"Shabbir Anik","position":1,"cik":"0001751728","reported_name":"Shabbir Anik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops. Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2018-09-27T17:49:07.000Z","date":"2018-09-26","kind":"grant","acquired":true,"shares":154958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2022, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":154958,"derivative":{"exercise_price":15,"expiration_date":"2028-09-25","underlying":"Common Stock","underlying_shares":154958},"source":{"system":"sec-edgar","filing":"0001209191-18-052477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751728/000120919118052477/doc4.xml","form_type":"4"}}]}